BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Nov. 16, 2018

View Archived Issues

Adaptive Biotechnologies, universities join in battle against type 1 diabetes

Read More

Federal Circuit kicks Nuvasive case back to PTAB for another look

The U.S. Court of Appeals for the Federal Circuit held another hearing involving a patent by Nuvasive Inc., of San Diego, for the company's Extreme lateral interbody fusion (XILF) system, during which the Federal Circuit vacated the Patent Trial and Appeal Board's (PTAB) finding of obviousness. The case isn't over yet, as the court remanded the case back to the board, where Nuvasive will have another chance to preserve the patent. Read More

Business development drives growth of regenerative medicine

Read More

Appointments and advancements

Read More

Product briefs

Read More

Regulatory front

Read More

Daily M&A

Read More

Financings

Read More

Other news to note

Read More

BioWorld MedTech's Diagnostics Extra

Read More

Smiths Group to spin out Minneapolis-based medical business, shares see 9 percent jump

Smiths Group plc has opted to separate its main business from its medical device unit, Smiths Medical. The London-based industrial conglomerate said that the move would allow the unit to reach its full potential by focusing on new product launches and market opportunities. The move is still in the early planning stages, with more details to come in March on the next earnings call. Read More

Newborns a focus for Chinese medical device makers

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing